Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 39; no. 1; pp. e1 - e4
Main Authors Rompoti, Natalia, Stefanaki, Irene, Panagakis, Pantelis, Papoutsaki, Marina, Politou, Maria, Vavouli, Charitomeni, Befon, Angeliki, Kousta, Fiori, Lazou, Eleni, Zaimi, Maria, Koumprentziotis, Ioannis‐Alexios, Chasapi, Vasiliki, Rigopoulos, Dimitrios, Stratigos, Alexander, Nicolaidou, Electra
Format Journal Article
LanguageEnglish
Published England 01.01.2025
Online AccessGet full text
ISSN0926-9959
1468-3083
1468-3083
DOI10.1111/jdv.19956

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0926-9959
1468-3083
1468-3083
DOI:10.1111/jdv.19956